Overview
The 71st Annual Meeting of the American Academy of Neurology (AAN) was held in Philadelphia, Pennsylvania, from May 4-10, 2019.
Conference highlights included movement in the rare disease space, namely pertaining to updated data in spinal muscular atrophy, early-phase data in amyotrophic lateral sclerosis, and pivotal data in neuromyelitis optica spectrum disorder. These were particularly noteworthy considering the lack of therapy options for these severe indications and the associated critical unmet need.
This post-meeting report features summaries of key topics alongside commentary from our team of expert analysts. It also includes a compilation of all data events added in conjunction with the meeting.
The 71st Annual Meeting of the American Academy of Neurology (AAN) was held in Philadelphia, Pennsylvania, from May 4-10, 2019.
Conference highlights included movement in the rare disease space, namely pertaining to updated data in spinal muscular atrophy, early-phase data in amyotrophic lateral sclerosis, and pivotal data in neuromyelitis optica spectrum disorder. These were particularly noteworthy considering the lack of therapy options for these severe indications and the associated critical unmet need.
This post-meeting report features summaries of key topics alongside commentary from our team of expert analysts. It also includes a compilation of all data events added in conjunction with the meeting.
Table of Contents
Meeting Overview – Key IndicationsAmyotrophic Lateral Sclerosis (ALS)Selected Abstracts Featured at AANList of Biomedtracker AAN Events
Migraine
Amyotrophic Lateral Sclerosis (ALS)
Essential Tremor
Migraine and Other Headaches
Myasthenia Gravis (MG)
Neuromyelitis Optica (Devic’s syndrome, NMO)
Parkinson's Disease (PD)
Seizure Disorders (Epilepsy)
Spinal Muscular Atrophy
